NCT05923060 2026-02-20
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
26 trialsNCT06623201 2026-01-29
Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas
US Dermatology Partners, Phoenix
Phase 1 Recruiting
NCT07053852 2026-01-02
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
Rochester Dermatologic Surgery
Phase 1 Completed
NCT06027619 2025-10-23
Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
NCT06159842 2025-02-12
Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
The Center for Clinical and Cosmetic Research
Phase 2 Completed
NCT03066843 2025-01-31
Photodynamic Therapy Incubation Times for Actinic Keratosis
Northwestern University
Phase NA Active not recruiting
NCT06745999 2024-12-24
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
Psoriasis Treatment Center of Central New Jersey
Phase 4 Recruiting
NCT06577311 2024-08-29
Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)
The Center for Clinical and Cosmetic Research
Phase 2 Recruiting
NCT03963102 2024-07-26
Duration of Ameluz Application in Acral Actinic Keratoses Response
Royal Cornwall Hospitals Trust
Phase 4 Terminated
NCT03327831 2024-06-27
Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses
University of California, Irvine
Phase 4 Completed
NCT03109353 2023-01-13
Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease
St. Olavs Hospital
Phase 1/2 Completed
NCT03322293 2022-03-09
Daylight Photodynamic Therapy for Actinic Keratosis
University of California, San Francisco
Phase 1 Completed
NCT02751151 2021-10-06
PDT
Inova Health Care Services
Phase NA Completed
NCT02867722 2021-02-01
DaylightPDT
Brigham and Women's Hospital
Phase NA Withdrawn
NCT01556009 2020-11-02
Vismodegib
UCSF Benioff Children's Hospital Oakland
Phase 2 Completed
NCT02157623 2020-07-30
Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
The Cleveland Clinic
Phase NA Completed
NCT02367547 2019-03-28
Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL
Joint Authority for Päijät-Häme Social and Health Care
Phase 1/2 Unknown
NCT03642535 2019-03-19
Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention
Shanghai Dermatology Hospital
Phase 4 Unknown
NCT02622594 2017-07-19
Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
Dermatology, Laser & Vein Specialists of the Carolinas
Phase 4 Completed
NCT00524485 2017-06-14
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
Roswell Park Cancer Institute
Phase NA Terminated
NCT00663910 2017-01-02
Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
The Cleveland Clinic
Phase EARLY_PHASE1 Terminated
NCT02647151 2016-01-06
Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
Fundación Instituto Valenciano de OncologÃa
Phase 4 Unknown
NCT01203878 2014-12-08
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Tennessee Clinical Research Center
Phase 4 Terminated
NCT00002975 2013-10-10
Photodynamic Therapy in Treating Patients With Skin Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT00002963 2013-01-31
Photodynamic Therapy in Treating Patients With Skin Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT00054171 2013-01-31
Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
Roswell Park Cancer Institute
Phase 2 Completed